Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Antimicrobial Protegrin-1 Forms Amyloid-Like Fibrils with Rapid Kinetics Suggesting a Functional Link
  2. Jang, H. J. H.; Arce, F. T.; Mustata, M.; Ramachandran, S.; Capone, R.; Nussinov, R.; Lal, R.
  3. Biophysical Journal. 2011, Apr; 100(7): 1775-1783.
  1. 2.   Nature, Position, and Frequency of Mutations Made in a Single Cycle of HIV-1 Replication
  2. Abram, M. E.; Ferris, A. L.; Shao, W.; Alvord, W. G.; Hughes, S. H.
  3. Journal of Virology. 2010, Oct; 84(19): 9864-9878.
  1. 3.   Human alpha-defensins block papillomavirus infection
  2. Buck, C. B.; Day, P. M.; Thompson, C. D.; Lubkowski, J.; Lu, W. Y.; Lowy, D. R.; Schiller, J. T.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2006, JAN 31; 103(5): 1516-1521.
  1. 4.   HPV-16 L1 VLP vaccine elicits a broad-spectrum of cytokine responses in whole blood
  2. Pinto, L. A.; Castle, P. E.; Roden, R. B.; Harro, C. D.; Lowy, D. R.; Schiller, J. T.; Wallace, D.; Williams, M.; Kopp, W.; Frazer, I. H.; Berzofsky, J. A.; Hildesheim, A.
  3. Vaccine. 2005, MAY 20; 23(27): 3555-3564.
  1. 5.   Induction of stem cell factor/c-Kit/Slug signal transduction in multidrug-resistant malignant mesothelioma cells
  2. Catalano, A.; Rodilossi, S.; Rippo, M. R.; Caprari, P.; Procopio, A.
  3. Journal of Biological Chemistry. 2004, NOV 5; 279(45): 46706-46714.
  1. 6.   Anti-HIV cyclotides
  2. Gustafson, K. R.; McKee, T. C.; Bokesch, H. R.
  3. Current Protein & Peptide Science. 2004, OCT; 5(5): 331-340.
  1. 7.   SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity. Part 2: Efficacy evaluations
  2. Alley, M. C.; Hollingshead, M. G.; Pacula-Cox, C. M.; W, W. R.; Hartley, J. A.; Howard, P. W.; Gregson, S. J.; Thurston, D. E.; Sausville, E. A.
  3. Cancer Research. 2004, SEP 15; 64(18): 6700-6706.
  1. 8.   Nonrandom HIV-1 infection and double infection via direct and cell-mediated pathways
  2. Dang, Q.; Chen, J. B.; Unutmaz, D.; Coffin, J. M.; Pathak, V. K.; Powell, D.; KewalRamani, V. N.; Maldarelli, F.; Hu, W. S.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(2): 632-637.
  1. 9.   Antineoplastic agents. 499. Synthesis of hystatin 2 and related 1H-benzo[de][1,6]-naphthyridinium salts from aaptamine
  2. Pettit, G. R.; Hoffmann, H.; Herald, D. L.; Blumberg, P. M.; Hamel, E.; Schmidt, J. M.; Chang, Y.; Pettit, R. K.; Lewin, N. E.; Pearce, L. V.
  3. Journal of Medicinal Chemistry. 2004 47(7): 1775-1782.
  1. 10.   Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine
  2. Pettit, G. R.; Hoffmann, H.; Herald, D. L.; McNulty, J.; Murphy, A.; Higgs, K. C.; Hamel, E.; Lewin, N. E.; Pearce, L. V.; Blumberg, P. M.; Pettit, R. K.; Knight, J. C.
  3. Journal of Organic Chemistry. 2004 69(7): 2251-2256.
  1. 11.   Y586F mutation in murine leukemia virus reverse transcriptase decreases fidelity of DNA synthesis in regions associated with adenine-thymine tracts
  2. Zhang, W. H.; Svarovskaia, E. S.; Barr, R.; Pathak, V. K.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2002 99(15): 10090-10095.
  1. 12.   A complete system for identifying inhibitors of creatine kinase B
  2. Towler, E. M.; Wilson, L. K.; Zhou, Y. C.; Ma, T. S.; Fisher, R. J.
  3. Analytical Biochemistry. 2000 279(1): 96-99.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel